Entity
Company
Location
Unit 5106 7, 51 St Floor, The Center 99 Queens Road Central, Central, Hong Kong
Signature
/s/ Loo See Yuen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857):

Stock Role Class Num Shares Value Price $ Report Date Ownership
IGC Pharma, Inc. 10%+ Owner COMMON STOCK 13.8M $4.7M $0.34 Mar 22, 2024 Direct

Insider Reports Filed by Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IGC IGC Pharma, Inc. Mar 22, 2024 1 $3M 4 May 13, 2024 10%+ Owner
IGC IGC Pharma, Inc. Jun 30, 2023 0 $0 3 May 13, 2024 Investor